DZ2512A1 - Compositions pour le traitement et la prévention de la thrombose artérielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinasion avec un antiagrégantplaquettaire. - Google Patents

Compositions pour le traitement et la prévention de la thrombose artérielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinasion avec un antiagrégantplaquettaire.

Info

Publication number
DZ2512A1
DZ2512A1 DZ980122A DZ980122A DZ2512A1 DZ 2512 A1 DZ2512 A1 DZ 2512A1 DZ 980122 A DZ980122 A DZ 980122A DZ 980122 A DZ980122 A DZ 980122A DZ 2512 A1 DZ2512 A1 DZ 2512A1
Authority
DZ
Algeria
Prior art keywords
prevention
compositions
factor
treatment
combination
Prior art date
Application number
DZ980122A
Other languages
English (en)
French (fr)
Inventor
Andre Bernat
Jean Marc Herbert
Maurice Petitou
Ronald Van Amsterdam
Original Assignee
Sanofi Sa
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa, Akzo Nobel Nv filed Critical Sanofi Sa
Application granted granted Critical
Publication of DZ2512A1 publication Critical patent/DZ2512A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DZ980122A 1997-06-13 1998-06-10 Compositions pour le traitement et la prévention de la thrombose artérielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinasion avec un antiagrégantplaquettaire. DZ2512A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9707368A FR2764511B1 (fr) 1997-06-13 1997-06-13 Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire

Publications (1)

Publication Number Publication Date
DZ2512A1 true DZ2512A1 (fr) 2003-02-01

Family

ID=9507960

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980122A DZ2512A1 (fr) 1997-06-13 1998-06-10 Compositions pour le traitement et la prévention de la thrombose artérielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinasion avec un antiagrégantplaquettaire.

Country Status (43)

Country Link
US (2) US6541488B1 (xx)
EP (1) EP0986376B1 (xx)
JP (1) JP3988803B2 (xx)
KR (1) KR100598451B1 (xx)
CN (1) CN1253150C (xx)
AR (1) AR012247A1 (xx)
AT (1) ATE384528T1 (xx)
AU (1) AU728826B2 (xx)
BR (1) BR9810520A (xx)
CA (1) CA2293415C (xx)
CO (1) CO4940476A1 (xx)
CY (1) CY1107912T1 (xx)
CZ (1) CZ299518B6 (xx)
DE (1) DE69839046T2 (xx)
DK (1) DK0986376T3 (xx)
DZ (1) DZ2512A1 (xx)
EE (1) EE04737B1 (xx)
ES (1) ES2299209T3 (xx)
FR (1) FR2764511B1 (xx)
GT (1) GT199800171A (xx)
HK (1) HK1032750A1 (xx)
HR (1) HRP980322B1 (xx)
HU (1) HU227956B1 (xx)
ID (1) ID29309A (xx)
IL (1) IL133452A (xx)
IS (1) IS2619B (xx)
ME (1) ME00685B (xx)
MY (1) MY124648A (xx)
NO (1) NO323739B1 (xx)
NZ (1) NZ501452A (xx)
PL (1) PL193405B1 (xx)
PT (1) PT986376E (xx)
RS (1) RS49902B (xx)
RU (1) RU2212886C2 (xx)
SA (1) SA98190552B1 (xx)
SI (1) SI0986376T1 (xx)
SK (1) SK286311B6 (xx)
TR (1) TR199903087T2 (xx)
TW (1) TW565442B (xx)
UA (1) UA70919C2 (xx)
UY (1) UY25044A1 (xx)
WO (1) WO1998056365A1 (xx)
ZA (1) ZA985137B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
US6344450B1 (en) 1999-02-09 2002-02-05 Bristol-Myers Squibb Company Lactam compounds and their use as inhibitors of serine proteases and method
US6297233B1 (en) 1999-02-09 2001-10-02 Bristol-Myers Squibb Company Lactam inhibitors of FXa and method
FR2793687B1 (fr) * 1999-04-26 2001-08-24 Sanofi Sa Nouvelle composition injectable d'un anticoagulant
FR2800074B1 (fr) * 1999-10-22 2001-12-21 Aventis Pharma Sa Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
US6544981B2 (en) 2000-06-09 2003-04-08 Bristol-Myers Squibb Company Lactam inhibitors of factor Xa and method
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
DE60217835D1 (en) * 2001-02-28 2007-03-15 John H Griffin Plasmaglucosylceramiddefizienz als risikofaktor für thrombose und modulator von anticoagulant protein c
UA80399C2 (en) * 2001-11-13 2007-09-25 Glaxo Group Ltd Use of specific dose of fondaparinux sodium for the treatment of acs
AU2003270861A1 (en) 2002-10-02 2004-04-23 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
EP1564213A4 (en) * 2002-11-22 2009-05-27 Takeda Pharmaceutical IMIDAZOLE DERIVATIVES, PROCESS FOR THE PRODUCTION AND USE THEREOF
JP4855073B2 (ja) * 2003-09-19 2012-01-18 キッセイ薬品工業株式会社 併用医薬
WO2005087266A1 (en) * 2004-03-05 2005-09-22 Vddi Pharmaceuticals Combination therapy for inhibition of platelet aggregation
AU2005236997B2 (en) * 2004-04-23 2010-04-29 Hitoshi Kiya Moving picture data encoding method, decoding method, terminal device for executing them, and bi-directional interactive system
TWI396686B (zh) * 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
US7563780B1 (en) * 2004-06-18 2009-07-21 Advanced Cardiovascular Systems, Inc. Heparin prodrugs and drug delivery stents formed therefrom
JP5557410B2 (ja) * 2004-07-13 2014-07-23 第一三共株式会社 経口投与による血栓・塞栓の予防治療剤
US20070105825A1 (en) * 2004-09-16 2007-05-10 Yuji Hoyano Concurrent drugs
CA2624867A1 (en) * 2005-10-10 2007-04-19 N.V. Organon Antithrombotic compound
WO2010029552A1 (en) * 2008-09-10 2010-03-18 Transpharma Medical Ltd. Transdermal delivery of oligosaccharides
WO2011149110A1 (en) 2010-05-28 2011-12-01 Daiichi Sankyo Company, Limited Novel composition for the prevention and/or treatment of thromboembolism
CA2966249C (en) * 2014-10-30 2019-06-18 Chengdu Baiyu Pharmaceutical Co., Ltd. Pharmaceutical composition containing ginkgolide b and xa factor inhibitor, preparation method thereof and use thereof
CN106860868B (zh) * 2015-12-11 2019-11-22 北京百奥药业有限责任公司 沙班类药物与蚓激酶的药物组合物、制剂及其应用
US11654036B2 (en) 2020-05-26 2023-05-23 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548189B1 (fr) * 1983-07-01 1986-04-11 Choay Sa Nouveaux produits contenant des oligosaccharides, leur preparation et leurs applications biologiques et biochimiques
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
FR2728901B1 (fr) * 1994-12-28 1997-03-28 Sanofi Sa Derives de phenyl-4-thiazoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
IL129877A (en) 1996-11-27 2004-08-31 Aventis Pharm Prod Inc A pharmaceutical preparation containing a component having an Xa antagonist activity and an antifouling agent
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire

Also Published As

Publication number Publication date
ZA985137B (en) 1999-01-07
EP0986376A1 (fr) 2000-03-22
EP0986376B1 (fr) 2008-01-23
ATE384528T1 (de) 2008-02-15
KR20010013690A (ko) 2001-02-26
DE69839046D1 (de) 2008-03-13
CA2293415C (en) 2011-08-09
US6541488B1 (en) 2003-04-01
SK170999A3 (en) 2000-07-11
KR100598451B1 (ko) 2006-07-10
PL337288A1 (en) 2000-08-14
GT199800171A (es) 2000-04-21
ES2299209T3 (es) 2008-05-16
CN1274281A (zh) 2000-11-22
SA98190552B1 (ar) 2006-09-09
AR012247A1 (es) 2000-09-27
JP3988803B2 (ja) 2007-10-10
HUP0002175A1 (hu) 2000-11-28
RU2212886C2 (ru) 2003-09-27
HK1032750A1 (en) 2001-08-03
DK0986376T3 (da) 2008-05-13
PT986376E (pt) 2008-04-01
PL193405B1 (pl) 2007-02-28
SK286311B6 (en) 2008-07-07
WO1998056365A1 (fr) 1998-12-17
UA70919C2 (uk) 2004-11-15
FR2764511A1 (fr) 1998-12-18
FR2764511B1 (fr) 2000-09-08
CN1253150C (zh) 2006-04-26
HUP0002175A3 (en) 2003-05-28
CO4940476A1 (es) 2000-07-24
UY25044A1 (es) 2000-10-31
IL133452A0 (en) 2001-04-30
ME00685B (me) 2008-08-07
NO996137D0 (no) 1999-12-10
CZ299518B6 (cs) 2008-08-20
IS5280A (is) 1999-11-30
TW565442B (en) 2003-12-11
IL133452A (en) 2004-09-27
BR9810520A (pt) 2000-09-19
CY1107912T1 (el) 2013-09-04
TR199903087T2 (xx) 2000-05-22
HU227956B1 (en) 2012-07-30
DE69839046T2 (de) 2009-01-15
JP2002504110A (ja) 2002-02-05
ID29309A (id) 2001-08-16
HRP980322A2 (en) 1999-04-30
CZ446099A3 (cs) 2000-04-12
US20040092477A1 (en) 2004-05-13
NO996137L (no) 2000-02-14
NO323739B1 (no) 2007-07-02
YU63699A (sh) 2002-06-19
EE04737B1 (et) 2006-12-15
HRP980322B1 (en) 2003-12-31
NZ501452A (en) 2002-06-28
AU728826B2 (en) 2001-01-18
RS49902B (sr) 2008-08-07
MY124648A (en) 2006-06-30
EE9900574A (et) 2000-08-15
SI0986376T1 (sl) 2008-06-30
CA2293415A1 (en) 1998-12-17
IS2619B (is) 2010-05-15
AU7924698A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
DZ2512A1 (fr) Compositions pour le traitement et la prévention de la thrombose artérielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinasion avec un antiagrégantplaquettaire.
NZ297118A (en) Antithrombotic formulation; comprises thrombin inhibitor and one or more absorption enhancing agents
DE59813922D1 (de) Wasch- und reinigungsmittel
EP1007089A4 (en) ANTI-COAGULATING AGENTS FOR USE IN THROMBOSIS TREATMENTS
DE69516976D1 (de) Verhinderung von Ablagerungen in Wassersystemen
DE69704820T2 (de) Hemmung von Schmutzniederschlägen in alkalischen Wäschern
IL120302A0 (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
ATE122206T1 (de) Verminderung und inhibition des gehalts von äthylenthioharnstoff in alkylenbisdithiocarbamaten.
GB9302891D0 (en) Appliances for cleaning or otherwise treating floor and other surfaces
PL339651A1 (en) Method of obtaining washing and cleaning agents in the form of solid formpieces
GB9302890D0 (en) Appliances for cleaning or otherwise treating floor and other surfaces
ITRM960104V0 (it) Perfezionamenti nei sistemi di scarico di apparecchi igienici e sani= tari in genere.
KR980003161U (ko) 방뇨시 방음 및 수적튀김방지 좌변기위생 보조기구
DE59711418D1 (de) Pulverförmige Wasch- und Reinigungsmittel-Komponente
DE29506747U1 (de) Dusch- und Badewannenmatte
KR960004703U (ko) 컵받침 겸 컨솔 도어
AU118564S (en) Bathroom and/or laundry accessory
DE9212120U1 (de) Syphon für den Sanitär- und Küchenbereich mit verbessertem Ablaufverhalten
FR2745985B1 (fr) Piece de vetement d'un seul tenant du type justaucorps ou body
KR950003653U (ko) 세차 및 샤워용 물백
KR950026707U (ko) 전자동발세척 겸 지압기
ITAL960004V0 (it) Mascherina che evita la pulizia ai piani di cotturaq di fornelli e cucine.
AU118563S (en) Bathroom and/or laundry accessory
AU118565S (en) Bathroom and/or laundry accessory
KR950009001U (ko) 세탁기의 물튀김방지 및 세척겸용 급수장치